Tuberculosis Research and Epidemiology

149 ta ish

1. Multidrug-resistant tuberculosis in Uzbekistan: results of a nationwide survey, 2010 to 2011

   Dilrabo Ulmasova, G Uzakova, M N Tillyashayhov +17

   MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyEurosurveillance201315 iqtibos

   ABIABI:AkademIndex/2026.other.163910

2. Multidrug-resistant Tuberculosis in Central Asia

   Helen Cox, Juan Daniel Orozco, Roy Male +6

   MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyEmerging infectious diseases20049 iqtibos

   ABIABI:AkademIndex/2026.other.020023

3. A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis

   Bern-Thomas Nyang’wa, Catherine Berry, Emil Kazounis +15

   MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyNew England Journal of Medicine20228 iqtibos

   ABIABI:AkademIndex/2022.article.000002

4. Factors Associated with Unfavorable Treatment Outcomes in New and Previously Treated TB Patients in Uzbekistan: A Five Year Countrywide Study

   Jamshid Gadoev, Damin Asadov, Mirzagolib Tillashaykhov +14

   MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyPLoS ONE20154 iqtibos

   ABIABI:AkademIndex/2015.article.000023

5. Where there is hope: a qualitative study examining patients’ adherence to multi-drug resistant tuberculosis treatment in Karakalpakstan, Uzbekistan

   Shona Horter, Beverley Stringer, Jane Greig +5

   MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyBMC Infectious Diseases20164 iqtibos

   ABIABI:AkademIndex/2016.article.000054

6. Effectiveness and safety of standardised shorter regimens for multidrug-resistant tuberculosis: individual patient data and aggregate data meta-analyses

   Faiz Ahmad Khan, M Salim, Philipp du Cros +9

   Sharh maqolaOAOchiq kirishTuberculosis Research and EpidemiologyEuropean Respiratory Journal20174 iqtibos

   ABIABI:AkademIndex/2017.review-article.000004

7. Acquired bedaquiline resistance in Karakalpakstan, Uzbekistan

   Parvati Nair, T. Hasan, K. K. Zaw +9

   MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease20224 iqtibos

   ABIABI:AkademIndex/2026.other.281624

8. The Beijing genotype and drug resistant tuberculosis in the Aral Sea region of Central Asia

   Helen Cox, Tanja Kubica, Daribay Doshetov +3

   MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyRespiratory Research20053 iqtibos

   ABIABI:AkademIndex/2005.article.000006

9. Health system support and health system strengthening: two key facilitators to the implementation of ambulatory tuberculosis treatment in Uzbekistan

   Stefan Köhler, Damin Asadov, Andreas Bründer +4

   MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyHealth Economics Review20163 iqtibos

   ABIABI:AkademIndex/2016.article.000128

10. Antituberculosis Activity and Pharmacokinetics of Polymer Conjugates of Isoniazid and Ethambutol

    Ш. А. Шомуротов, Oliy Ravshanovich Akhmedov, А. С. Тураев +1

    MaqolaInfectious Diseases and TuberculosisPharmaceutical Chemistry Journal20213 iqtibos

    ABIABI:AkademIndex/2021.article.001447

11. Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan

    James M. Trauer, Jay Achar, Nargiza Parpieva +7

    MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyBMC Medicine20163 iqtibos

    ABIABI:AkademIndex/2026.other.195695

12. Person-centred care in practice: perspectives from a short course regimen for multi-drug resistant tuberculosis in Karakalpakstan, Uzbekistan

    Shona Horter, Beverley Stringer, Nell Gray +5

    MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyBMC Infectious Diseases20203 iqtibos

    ABIABI:AkademIndex/2026.other.195708

13. Scaling Up Molecular Diagnostic Tests for Drug-Resistant Tuberculosis in Uzbekistan from 2012–2019: Are We on the Right Track?

    Sharofiddin Yuldashev, Nargiza Parpieva, Salikhdjan Alimov +6

    MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20213 iqtibos

    ABIABI:AkademIndex/2026.other.262609

14. ‘They prefer hidden treatment': anti-tuberculosis drug-taking practices and drug regulation in Karakalpakstan

    Beverley Stringer, Karen Lowton, Mirzagaleb N. Tillashaikhov +5

    MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease20162 iqtibos

    ABIABI:AkademIndex/2016.article.000087

15. Trends, Characteristics and Treatment Outcomes of Patients with Drug-Resistant Tuberculosis in Uzbekistan: 2013–2018

    Khasan Safaev, Nargiza Parpieva, Irina Liverko +5

    MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20212 iqtibos

    ABIABI:AkademIndex/2021.article.000207

16. Effectiveness and Safety of a Shorter Treatment Regimen in a Setting with a High Burden of Multidrug-Resistant Tuberculosis

    Aleksandr Trubnikov, Arax Hovhannesyan, Kristina Akopyan +5

    MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20212 iqtibos

    ABIABI:AkademIndex/2026.other.262608

17. Primary bedaquiline resistance in Karakalpakstan, Uzbekistan

    S. Moe, M. L. Rekart, D. Hernandez +9

    MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease20232 iqtibos

    ABIABI:AkademIndex/2026.other.281628

18. Ambulatory tuberculosis treatment in post-Semashko health care systems needs supportive financing mechanisms

    Stefan Köhler, Damin Asadov, Andreas Bründer +4

    MaqolaHIV/AIDS Impact and ResponsesThe International Journal of Tuberculosis and Lung Disease20142 iqtibos

    ABIABI:AkademIndex/2026.other.364601

19. Tuberculosis Recurrence and Mortality after Successful Treatment: Impact of Drug Resistance

    Helen Cox, Yared Kebede, Sholpan Allamuratova +8

    MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyPLoS Medicine20061 iqtibos

    ABIABI:AkademIndex/2006.article.000008

20. Delay in the diagnosis and treatment of pulmonary tuberculosis in Uzbekistan: a cross-sectional study

    Tatiana Belkina, Doniyor S Khojiev, Mirzagaleb Tillyashaykhov +4

    MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyBMC Infectious Diseases20141 iqtibos

    ABIABI:AkademIndex/2014.article.000040

21. Revised Definitions of Multidrug-Resistant Tuberculosis Treatment Outcomes: Closer to the Reality?

    Mathieu Bastard, Maryline Bonnet, Philipp du Cros +9

    BoshqaTuberculosis Research and EpidemiologyAmerican Journal of Respiratory and Critical Care Medicine20151 iqtibos

    ABIABI:AkademIndex/2015.other.000002

22. Recurrent tuberculosis and associated factors: A five - year countrywide study in Uzbekistan

    Jamshid Gadoev, Damin Asadov, Anthony Harries +9

    MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyPLoS ONE20171 iqtibos

    ABIABI:AkademIndex/2017.article.000063

23. Impact of pyrazinamide resistance on multidrug-resistant tuberculosis in Karakalpakstan, Uzbekistan

    Johanna Kuhlin, Chris Smith, Atadjan Khaemraev +8

    MaqolaTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease20181 iqtibos

    ABIABI:AkademIndex/2018.article.000181

24. Standardised shorter regimens <i>versus</i> individualised longer regimens for rifampin- or multidrug-resistant tuberculosis

    S.K. Abidi, Jay Achar, M.M. Assao Neino +34

    MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyEuropean Respiratory Journal20191 iqtibos

    ABIABI:AkademIndex/2019.article.000020

25. Population structure of drug-resistant Mycobacterium tuberculosis in Central Asia

    A. Engström, Uladzimir Antonenka, Abdylat Kadyrov +10

    MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyBMC Infectious Diseases20191 iqtibos

    ABIABI:AkademIndex/2019.article.000129